Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2026-03-03 @ 3:06 PM
Study NCT ID:
NCT03208335
Status:
UNKNOWN
Last Update Posted:
2017-07-05
First Post:
2017-07-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-02
First Submit QC Date:
None
Study First Post Date:
2017-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-02
Last Update Post Date:
2017-07-05
Last Update Post Date Type:
ACTUAL